Enhancement of the antitumor activity of 5-fluorouracil by drug combinations.
D000818:Animals; D001835:Body Weight; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002452:Cell Count; D005467:Floxuridine / Q000008:administration & dosage / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013997:Time Factors; D014184:Transplantation, Homologous; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D005467:Floxuridine; D014747:Vinblastine; D005472:Fluorouracil; D006918:Hydroxyurea